Cutaneous leishmaniasis in Burkina Faso: Epidemiological evolution of a vector-borne disease locally called “Ouaga 2000 disease”: a minireview
https://dx.doi.org/10.4314/njpar.v44i1.25
Keywords:
Burkina Faso, Treatment, Diagnosis, Vector, Incidence, Cutaneous, LeishmaniasisAbstract
In Burkina Faso, the first case of cutaneous Leishmaniasis (CL) dates from 1960 and a few cases were reported in the following years. The objective of this review was to collect and analyze available data on CLin Burkina Faso to improve case management and control of disease transmission. A review of the literature was carried out using the PubMed, Google Scholar and Hinari databases. Publications dealing with the epidemiological aspects of CL, the parasite species involved, vectors and potential reservoir hosts, as well as drugs used in the treatment of CLwere searched. From 1960 to 1961, Burkina Faso recorded 13 cases of CL. From 2000 to 2005, an average of more than 1500 CLcases were recorded in Ouagadougou. In 2016 authors reported the results of the investigation of a second epidemic focus in Larama, Bassins region. More recently, in 2021, an investigation was carried out in a focus in the Centre-Nord region, bringing the number of CL focus to three in Burkina Faso. Leishmania major is the main species identified. In the wild area in the Ouagadougou focus, rodents Mastomys, Cricetomys, etc. have been described as the potential reservoir hosts, while in the domestic area, the animal reservoir would be the dog. In the focus of Ouagadougou, Phlebotomus duboscqi has been suspected since the 1960s as the possible vector of CL. The diagnosis is essentially microscopic. The first-line treatment meglumine antimoniate (Glucantime) accounted for only 65.9% of prescriptions. According to studies, the relapse rate after the first treatment with pentavalent antimony is about 37%. Despite the neglected disease status given to CL, there is therefore a need to strengthen the fight against this parasitosis by improving access to diagnosis and treatment, vector control and investigations to discover possible new endemic foci.
References
Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]. (2018). Global leishmaniasis surveillance update, 1998–2016–Le point sur la situation mondiale de la leishmaniose, 1998-2016. Weekly Epidemiological Record=Relevé épidémiologique hebdomadaire, vol. 93, no 40, p. 530-540.
Konate, I., Sangare, I., Zoungrana, J., Meda, Z. C., Kafando, C., Sawadogo, Y., Dabiré, R., Meda, N., Diallo, B., Andonaba, J. B., Barro-Traoré, F., Niamba, P., and Traoré, A. (2020).Description of a new epidemic focus of cutaneous Leishmaniasis major in western Burkina Faso. Pan African Medical Journal.Mar 6; 35: 65. French. doi:10.11604/pamj.2020.35.65.20825.
Cissé, M., Zida, A., Diallo, A. H., Marty, P., and Aoun, K. (2020). Epidemiology of Cutaneous Leishmaniasis in West Africa: a Systematic Review. Bulletin de la Société de Pathologie Exotique. 113(1):24-34. French. doi: 10.3166/bspe-2020-0115.
Oddou, A. (1960). Leishmaniose cutanée en Haute Volta. Bulletin de la Société de Médecine d'Afrique Noire langueFrançaise.7:284-7.
Ministère de la Santé. (2020). Plan national de développement sanitaire 2011-2020-Burkina Faso. 51
Bamba, S., Gouba, A., Drabo, K. M., Ne z i en, D., Bougoum, M., and Guiguemdé, T. R. (2011 Trends inincidence of cutaneous leishmaniasis from 1999 to 2005 in Ouagadougou, Burkina. Médecine Tropicale. 71(3):312
Bamba, S., Gouba, A., Drabo, M. K., Ne z i en, D., Bougoum, M., andGuiguemdé, T. R. (2013). Epidemiological profile of cutaneous leishmaniasis:retrospective analysis of 7444 cases reported from 1999 to 2005 at Ouagadougou, Burkina Faso. Pan African Medical Journal. 14:108. doi:10.11604/pamj.2013.14.108.1140.PMID: 23717722.
Harrat, Z., Pratlong, F., Benikhlef, R., Lami, P., Belkaid, M. and Dedet, J. P.(1998). Leishmania major MON-74 as a causative agent of cutaneous leishmaniasis in Burkina Faso. Transactions of the Royal Society of Tropical Medicine and Hygiene.92(3):355. doi:10.1016/s0035-9203(98)91041-0.
Niamba, P., Traoré, A., Goumbri-Lompo, O., Labrèze, C., Traoré-Barro, F.,Bonkoungou, M., Ilboudo, L., Gaulier, A., and Soudré, B. R. (2006). Cutaneous l e ishmani a sis in HIV pa ti ent in Ouagadougou: clinical and therapeuticaspects. Annales de Dermatologie et de Vénéréologie. 133(6-7):537-42. French. doi: 10.1016/s0151-9638(06)70958-9.
Traoré, K. S., Sawadogo, N. O., Traoré, A., Ouedraogo, J. B., Traoré, K. L., and Guiguemdé, T. R. (2001). Preliminary study of cutaneous leishmaniasis in the town of Ouagadougou from 1996 to 1998. Bulletin de la Société de Pathologie Exotique. 94(1):52-5.
Sunyoto, T., Verdonck, K., El Safi, S., Potet, J., Picado, A. and Boelaert, M.(2018). Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa-Asystematic review. PLOS Neglected Tropical Diseases. 25;12(10):e0006914. doi:10.1371/journal.pntd.000691
Guiguemdé, R. T., Sawadogo, O. S., Bories, C., Traore, K. L., Nezien, D., Nikiema, L., Pratlong, F., Marty, P., Houin, R. and Deniau, M. (2003).
Leishmania major and HIV co-infection in Burkina Faso. Transactions of the Royal Society of Tropical Medicine and Hygiene. 97(2):168-9. doi: 10.1016/s0035-9203(03)90109-
Barro-Traoré, F., Preney, L., Traoré, A., Darie, H., Tapsoba, P., Bassolé, A.,Sawadogo, S., Niamba, P., Grosshans, E. and Geniaux, M. (2008). Cutaneousleishmaniasis due to Leishmania majorinvolving the bone marrow in an AIDS patient in Burkina Faso. Annales de Dermatologie et de Vénéréologie. 135(5): 380-3.French.doi:10.1016/j.annder.2007.10.005
Bonkoungou, M., Traoré, F., Tapsoba, G., Sidnoma Ouedraogo, M., NomtondoOuédraogo, A., Kafando, Y., Zeba, S., Korsaga/Somé, Barro/Traoré, F., Niamba, A. and Traoré, A. (2020).Mutilation Centrofaciale : Penser à une Leishmaniose Cutanéo-Muqueuse chez le Patient Infecté par le VIH. Health Sciences and Disease. 21(6). Retrieved from http://www.hsd-fmsb.org/index.php/hsd/article/view/2063
Diakité, D., Dahourou, L. D., Barry, D., Bicaba, B. W., Yanogo, P. K., Nikiéma, M., Ilboudo, L. B., Ki-Zerbo, L. C., Nikiéma, and Nikolas, M. (2022). Investigation des cas de leishmaniose cutanée dans l'aire de Sante de Zandkoom, District Sanitaire Kongoussi, Centre-Nord, Burkina Faso, août 2021, Revue d'Épidémiologie et de Santé Publique. Volume 70, Supplement 3, 2022, Pages S159- S160, https://doi.org/10.1016/j.respe.2022.06.08.
Andonaba, J. B., Konaté, I., Diallo, B., Sangaré, I., Meda, N., Zoungrana, J., Kanfado, C., Sawadogo, G., Bationo, J. F., Sawadogo, Y., Dabiré, R. and Traoré, A.(2016). La leishmaniose cutanée: un deuxième foyer épidémique à Leishmania major au Burkina Faso. Annales de Dermatologie et de Vénéréologie. Volume 143, Issue 4, Supplement 1, P24,doi.org/10.1016/S0151-9638(16)30138-7.
Bamba, S., Barro-Traoré, F., Drabo, M. K., Gouba, A., Traoré, A. and Guiguemdé, T. R. (2013). Epidemiological profile, clinical and therapeutic cutaneous leishmaniasis in the Department of Dermatology at University Hospital in Ouagadougou, Burkina Faso. Revue Médicale de Bruxelles. 34(5):392-6.
Zida, A., Sangare, I., Nezien, D., Bretagne, S., Bamba, S., Deniau, M. and Guiguemde, R. T. (2020). Mastomys natalensis, Cricetomys ambianus and Taterillus sp. were found PCR positive for Leishmania major in Burkina Faso, West Africa. Annals of Parasitology 66(2):251-
doi: 10.17420/ap6602.262.
Djibougou, A. D., Nikièma, A. S., Hien, A. S., Sangaré, I., Yameogo, B. K., Koala, L., Ouari, A., Diagbouga, S. P., Diabaté, A., Price, H., Fournet, F. and Dabiré, R. K.(2022). Serological and molecular detection of Leishmania species in dog peripheral blood from Bobo-Dioulasso city, a confirmation of canine leishmaniasis enzootic area for Burkina Faso. Infection, Genetics and Evolution, 103:105327.doi:10.1016/j.meegid.2022.105327.
Robert-Gangneux, F., Baixench, M. T., Piarroux, R., Pratlong, F. and TourteSchaefer, C. (1999). Use of molecular tools for the diagnosis and typing of a Leishmania major strain isolated from an HIV-infected patient in Burkina Faso. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93(4):396-7. doi: 10.1016/s0035-9203(99)90130-x.
Coulibaly, N. D. and Yameogo, K. R.(2000). Prevalence and control of zoonotic diseases: collaboration between publichealth workers and veterinarians in Burkina Faso. Acta Tropica, 76(1):53-7. doi:10.1016/s0001-706x(00)00090-5.
Maroli, M., Fausto, A. M., Sabatinelli, G., and Majori, G. (1986). Phlebotomines (Diptera, Psychodidae) from Burkina Faso. A note on the sandfly species collected in domestic resting sites. Annales de parasitologie humaine et comparée, 161(6): 683-8.doi:10.1051/parasite/1986616683. P
Sangare, I., Gantier, J. C., Koalaga, G., Deniau, M., Ouari, A. and Guiguemdé, R. T. (2009). Sandflies of the south part of Ouagadougou City, Burkina Faso. Parasite, 16(3): 231- 3.doi:10.1051/parasite/2009163231.
Depaquit, J., Muller, F., Gantier, J. C., Leger, N., Ferte, H., Ready, P. and Niang, A. A. (2005). Phlebotomine sand flies from Ouagadougou, Burkina Faso: first record of Phlebotomus (Larroussius) longicuspis south of the Sahara. Medical and Veterinary Entomology, 19(3):322 - 5.doi:10.1111/j.1365-2915.2005.00561.x.
Kone, A. K., Niaré, D. S., Piarroux, M., Izri, A., Marty, P., Laurens, M. B., Piarroux, R., Thera, M. A. and Doumbo, O. K. (2019). Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs. Journal ofParasitology Research. 2019:9282690. doi:
1155/2019/9282690.
Noyes, H. A., Reyburn, H., Bailey, J. W. and Smith, D. (1998). A nested-PCR-based schizodeme method for identifyingLeishmania kinetoplast minicircle classes directly from clinical samples and itsapplication to the study of the epidemiology of Leishmania tropica in Pakistan. Journal of Clinical Microbiology, 36(10):2877-81. doi: 10.1128/JCM.36.10.2877-2881.1998.PMID: 9738037; PMCID: PMC105081.
Barro-Traoré, F., Preney, L., Traoré, A., Darie, H., Tapsoba, P., Bassolé, A.,Sawadogo, S., Niamba, P., Grosshans, E., and Geniaux, M. (2007). CO26-Premier cas de leishmaniose cutanée à Leishmania majoravec extension viscérale à la moelle chez un patient infecté par le VIH au Burkina Faso. Annales de Dermatologie et de Vénéréologie(Vol. 134, No. 1, p. 42). Elsevier Masson.
Kimutai, A., Ngure, P., and Tonui, W.(2009). Leishmaniasis in Northern and Western Africa: a review. African Journal of Infectious Diseases. Vol. 3, no 1.
Erber, A. C., Arana, B., Ben Salah, A., Bennis, I., Boukthir, A., Castro Noriega, M. D. M., Cissé, M., Cota, G. F., Handjani, F., López-Carvajal, L., Marsh, K.,Medina, D. M., Plugge, E., Lang, T. and Olliaro, P. (2020). Patients' preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study. PLOS Neglected Tropical Diseases. 14(2):e0007996. doi:10.1371/journal.pntd.0007996.
Niamba, P., Goumbri-Lompo, O., Traoré, A., Barro-Traoré, F. and Soudré, R. T.(2007). Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa. Australasian Journal of Dermatology, 48(1): 32 - 4. doi: 10.1111/j.1440-0960.2007.00323.x.
Andonaba, J. B. (2010). Aspects épidémiologiquesdes affections dermatologiques au Centre HospitalierUniversitaire Souro SANOU de BoboDioulasso. Annales Africaines de Médecine. Vol. 4, no 1, p. 668.
- Sawadogo, W. R., Le Douaron, G.,Maciuk, A., Bories, C., Loiseau, P. M., Figadère, B., et a Guissou, I. P. and Nacoulma, O. G. (2012). In vitro antileishmanial and antitrypanosomal activities of five medicinal plants from Burkina Faso. Parasitology Research, 110(5):1779-83. doi: 10.1007/s00436-011-2699-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
